CD8A and myeloid sarcoma: Because our cohort included both MS patients and controls and the somatic mutations were present in similar frequencies in patients and controls, we conclude that CD8+ cell STAT3 somatic mutations with low allele fraction are common in the CD8+ cells in the general population.